3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
5
Sarcoma
1
Myeloid
1
Conditions
Myelodysplastic Syndromes
211
Leukemia, Myeloid, Acute
181
Precursor Cell Lymphoblastic Leukemia-Lymphoma
162
Leukemia
125
Lymphoma, Non-Hodgkin
112
Hodgkin Disease
102
Leukemia, Lymphocytic, Chronic, B-Cell
99
Multiple Myeloma
97
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
91
Lymphoma
88
Myeloproliferative Disorders
87
Lymphoma, Follicular
72
Leukemia, Myelomonocytic, Chronic
72
Leukemia, Myeloid, Chronic-Phase
71
Lymphoma, Mantle-Cell
70
Burkitt Lymphoma
67
Leukemia, Myeloid, Accelerated Phase
65
Primary Myelofibrosis
62
Lymphoma, B-Cell, Marginal Zone
61
Lymphoma, Large B-Cell, Diffuse
60
Blast Crisis
53
Anemia, Refractory, with Excess of Blasts
51
Lymphoma, Large-Cell, Immunoblastic
50
Congenital Abnormalities
50
Neoplasms, Plasma Cell
47
Myelodysplastic-Myeloproliferative Diseases
45
Dendritic Cell Sarcoma, Interdigitating
41
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
38
Graft vs Host Disease
38
Leukemia, Biphenotypic, Acute
37
Interventions
etoposide phosphate
1
Sirolimus
1
Fentanyl
1
Etoposide
1
Cyclophosphamide
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pinealoma
×
Cyclophosphamide
×
Myeloid
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled